Trends Endocrinol Metab 31:410421 Sassin AM, Sangi-Haghpeykar H, Aagaard KM, Detti L (2023) Effects of metformin alone versus metformin and tirzepatide on weight loss in patients with polycystic ovarian syndrome (PCOS)
This is great for women trying to become pregnant and potentially risky for those trying to avoid pregnancy
Pancreatitis and gallbladder disease, though uncommon, are recognised risks associated with GLP-1 receptor agonist use, as documented in the Summary of Product Characteristics (SmPC) for licensed agents in this class (such as semaglutide)
To our knowledge, the strategy of selective prevention of cytotoxicity of cardiac vascular cells following MI and/or IRI to affect whole-organ cardioprotection has never been directly studied
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295
Share: A new study from the University of California San Diego suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes, may have benefits that extend far beyond blood sugar and weight management